Cullinan Therapeutics, Inc. (CGEM)
11.70
+0.39
(+3.45%)
USD |
NASDAQ |
Nov 09, 16:00
11.70
0.00 (0.00%)
After-Hours: 20:00
Cullinan Therapeutics Total Return Level : 11.31 for Nov. 6, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 06, 2026 | 11.31 |
| November 05, 2026 | 10.80 |
| November 04, 2026 | 12.49 |
| November 03, 2026 | 15.75 |
| November 02, 2026 | 14.93 |
| October 30, 2026 | 15.03 |
| October 29, 2026 | 15.45 |
| October 28, 2026 | 15.56 |
| October 27, 2026 | 14.84 |
| October 26, 2026 | 14.54 |
| October 23, 2026 | 14.37 |
| October 22, 2026 | 14.92 |
| October 21, 2026 | 14.89 |
| October 20, 2026 | 14.83 |
| October 19, 2026 | 13.98 |
| October 16, 2026 | 12.93 |
| October 15, 2026 | 14.00 |
| October 14, 2026 | 13.64 |
| October 13, 2026 | 14.10 |
| October 12, 2026 | 14.95 |
| October 09, 2026 | 15.53 |
| October 08, 2026 | 15.46 |
| October 07, 2026 | 15.63 |
| October 06, 2026 | 16.25 |
| October 05, 2026 | 16.04 |
| Date | Value |
|---|---|
| October 02, 2026 | 15.51 |
| October 01, 2026 | 14.53 |
| September 30, 2026 | 15.35 |
| September 29, 2026 | 15.23 |
| September 28, 2026 | 14.95 |
| September 25, 2026 | 14.81 |
| September 24, 2026 | 15.44 |
| September 23, 2026 | 16.87 |
| September 22, 2026 | 21.67 |
| September 21, 2026 | 21.35 |
| September 18, 2026 | 21.08 |
| September 17, 2026 | 21.36 |
| September 16, 2026 | 20.63 |
| September 15, 2026 | 20.54 |
| September 14, 2026 | 20.40 |
| September 11, 2026 | 20.59 |
| September 10, 2026 | 21.00 |
| September 09, 2026 | 21.31 |
| September 08, 2026 | 21.69 |
| September 04, 2026 | 22.09 |
| September 03, 2026 | 22.16 |
| September 02, 2026 | 22.33 |
| September 01, 2026 | 21.79 |
| August 31, 2026 | 22.07 |
| August 28, 2026 | 21.70 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Climb Bio, Inc. | 10.29 |
| MapLight Therapeutics, Inc. | 6.93 |
| Arrowhead Pharmaceuticals, Inc. | 58.16 |
| Oncolytics Biotech, Inc. | 0.4394 |
| Sangamo Therapeutics, Inc. | 0.114 |